Sinopia Biosciences' Grant - V Round

Sinopia Biosciences raised a round of funding on June 22, 2017. Investors include National Institutes of Health.

Sinopia is a computational biology company focusing on identifying and repurposing drugs to prevent or lower the serious side effects of major therapeutics. The company uses its proprietary machine le…

Articles about Sinopia Biosciences' Grant - V Round: